Trial intelligence / Profile preview

Ethyl chloride spray vs subcutaneous lidocaine for pain reduction during two-rod contraceptive implant insertion

TCTR20201218001Phase 4Completed

Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ethyl chloride, lidocaine, sponsored by None. Started Jan 2021; status: completed.

02

Drugs

ethyl chloridelidocaine

Beyond the preview

Go deeper on TCTR20201218001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20201218001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call